Publications

[vaccines against varicella-zoster virus (vzv)].	in western countries, two attenuated varicella vaccines derived from the oka strain are licensed: varilrix® glaxosmithkline (oka/rit strain) and varivax® merck sharp and dohme (oka/merck strain). currently, in spain, varicella vaccination is only included in the ministry of health, social services and equality official vaccination calendar for administration in adolescents who have not had the disease. given the good results obtained in navarra and madrid with universal administration of the vac ...	2017	26096575
effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in navarre, spain.	varicella vaccine effectiveness was evaluated in a case-control study in navarre, spain, in 2010-2012. the cases were 54 children aged 15 months to 10 years with a diagnosis of varicella confirmed by polymerase-chain-reaction. each case was matched with eight controls by pediatric practice, district of residence and date of birth. the effectiveness was 87% (95% confidence interval: 60% to 97%) for one dose of vaccine and 97% (80% to 100%) for two doses. a single dose was 93% (34% to 100%) effect ...	2013	23324571
[varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in navarre, 2005-2006].	varicella is an acute and highly contagious disease produced by the varicella-zoster virus, which leaves lasting immunity. herpes zoster is produced by reactivation of a latent infection of the same virus. the introduction of systematic and free vaccination against varicella in children of 15 months in navarre from 2007 onwards can be expected to produce important epidemiological changes. for this reason we describe the previous epidemiological situation in the period from 2005 to 2006. we analy ...	2008	18496581